Best Biopharma Outsourcing Companies in Israel
The 36 best Biopharma Outsourcing companies in Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: FutuRx.
- market.us
- ResearchAndMarkets.com
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Israel
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | FutuRx Startup accelerator and incubator focused on Biotech | $50M | 87 mo ago | Series B | Kinneret Livnat-Savitzky CEO | 2013 | WordPressMySQLPHP+10 | — | — |
| 2 | SpliSense Limited information available | $29M | 64 mo ago | Series B | — | 2016 | WordPressMySQLPHP+15 | 51 patents Antisense oligonucleotide therapies modulating mucin and CFTR splicing for respiratory disease | — |
| 3 | Procognia Contract research services for glycosylation and protein function studies | $24M | 262 mo ago | Public | Nir Peleg Ceo | 2000 | — | 14 patents Glycan and carbohydrate polymer analysis for disease diagnostics via saccharide binding | — |
| 4 | Pangea Biomed Proprietary platform offering response prediction for dozens of cancer types | $12M | 45 mo ago | Seed | Eyal Gottlieb Founder | 2018 | — | 9 patents Patents concentrated in computing, sensing & instrumentation | — |
| 5 | Scala Biodesign Provider of computational protein design solutions at scale | $6M | 5 mo ago | Series A | Adi Goldenzweig Co-Founder & CTO | 2021 | WixSentryBootstrap+14 | — | — |
| 6 | Scinai Provider of immuno-therapeutics solutions for the healthcare industry | $3M | 32 mo ago | Public | — | 2023 | Cart FunctionalitySquarespace CommerceSquarespace+23 | — | — |
| 7 | Pluri Developer of three-dimensional cell expansion platforms for various industries | — | 5 mo ago | Public | Yaky Yanay CEO | 2003 | WordPressMySQLPHP+23 | — | — |
| 8 | 1E Therapeutics Developer of programmable oligonucleotide therapeutics for silencing disease-causing RNAs | — | — | Unfunded | — | 2020 | — | 77 patents Therapeutic DNAzyme-based gene silencing and targeted mRNA cleavage technologies | — |
Top 7 Biopharma Outsourcing companies in Israel
#1
Series A · Tel Aviv, Tel Aviv · founded 2021$5.5Mraised▾
It is a company that specializes in computational protein design solutions. They offer unique one-shot solutions to increase value and accelerate protein design processes.
- Mar 2026Series A$16M
- Sep 2023Seed$5.5M
#2
Seed · Tel Aviv, Tel Aviv · founded 2018 · 21 employees$12Mraised▾
Proprietary platform offering response prediction for dozens of cancer types
- Dec 2022Seed$5M
- Apr 2022Seed$7M
#3
Series B · Ness Ziona, Center District · founded 2013 · 18 employees$49.7Mraised▾
FutuRx is a startup accelerator and incubator. The incubation period spans over 3 years and accepts startups working in the Biotech sector.
- May 2019Series B$19.7M
- May 2017Series A$30M
#4
Series B · Jerusalem, Jerusalem District · founded 2016 · 13 employees$28.9Mraised▾
Developer of novel drug candidates designed to heal splicing mutations in genetic diseases. The company's drug candidates are based on antisense oligonucleotides focusing on splicing mutations in the CFTR gene, enabling medical practitioners to treat cystic fibrosis.
- May 2021Series B$28.5M
- 2017Grant (prize money)$400K
#5
Public · Jerusalem, Jerusalem District · founded 2023 · 33 employees$3Mraised▾
Scinai Immunotherapeutics is a company that enables companies to go beyond carbon accounting and implement cost-effective carbon reduction strategies. They provide a decarbonization platform that helps companies take action towards reducing their carbon footprint.
- Dec 2023Post IPO$1.7M
- Nov 2023Grant (prize money)—
- Oct 2023Post IPO$1.3M
#6
Public · Rehovot, Central District · founded 2000$23.8Mraised▾
Procognia, formerly known as Glycodata, provided contract research services for glycosylation and protein function studies. Its platform technology was a protein microarray that enabled analysis of protein glycosylation. Applications included drug discovery and development for biopharmaceutical companies. The company had an ongoing partnership with Teva, and in Jan 2003, acquired Sense Proteomic to expand its service portfolio. The company is deadpooled.
#7
Public · Haifa, Haifa District · founded 2003 · 134 employees—raised▾
Developer of three-dimensional cell expansion platforms for various industries. The platforms efficiently grow cells applicable to plant, animal, and human types. The company focuses on manufacturing products and solutions for pharmaceutical and other industries. It also provides services related to clinical research.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Israel
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 267 Israel-affiliated papers.
- Ministry of Agriculture118
- Hebrew University of Jerusalem29
- Agricultural Research Organization25
- Tel Aviv University21
- Ben-Gurion University of the Negev19
- Mitochondrion1→5
- Gene1→18
- Plant disease resistance1→7
- Resistance (ecology)2→6
- Agriculture3→6
Where biotechnology is researched across Israel
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.